Abstract:figure legend Auditory outer hair cells are the cochlear amplifier essential for normal hearing sensitivity and frequency selectivity. This study used both cell lines and a mouse model to define the pathogenic role of compound heterozygous p.W70X (c.209G>A) and p.R130S (c.390A>C) SLC26A5 variants identified in patients with moderate to profound hearing loss. We found that the p.W70X nonsense variant results in a null prestin allele, and that mice carrying one copy of p.R130S (Slc26a5R130S/‐) as in human patients (SLC26A5W70X/R130S) suffer from congenital hearing loss and subsequent premature outer hair cell loss. The latter are both ascribed to slowed motor function of p.R130S prestin, as demonstrated in our preceding studies. Given the recessive nature of prestin‐associated hearing loss, DFNB61, this study points to the presence of a therapeutic time window for potential clinical interventions targeting the affected OHCs before they are lost. DFNB61 is a recessively inherited nonsyndromic hearing loss caused by mutations in SLC26A5, the gene that encodes the voltage‐driven motor protein, prestin. Prestin is abundantly expressed in the auditory outer hair cells that mediate cochlear amplification. Two DFNB61‐associated SLC26A5 variants, p.W70X and p.R130S, were identified in patients who are compound heterozygous for these nonsense and missense changes (SLC26A5W70X/R130S). Our recent study showed that mice homozygous for p.R130S (Slc26a5R130S/R130S) suffer from hearing loss that is ascribed to significantly reduced motor kinetics of prestin. Given that W70X‐prestin is nonfunctional, compound heterozygous Slc26a5R130S/− mice were used as a model for human SLC26A5W70X/R130S. By examining the pathophysiological consequences of p.R130S prestin when it is the sole allele for prestin protein production, we determined that this missense change results in progressive outer hair cell loss in addition to its effects on prestin's motor action. Thus, this study defines the pathogenic roles of p.R130S prestin and identifies a limited time window for potential clinical intervention. Key points The voltage‐driven motor protein, prestin, is encoded by SLC26A5 and expressed abundantly in cochlear outer hair cells (OHCs). The importance of prestin for normal hearing was demonstrated in mice lacking prestin; however, none of the specific SLC26A5 variants identified to date in human patients has been experimentally demonstrated to be pathogenic. In this study we used both cell lines and a mouse model to define the pathogenic role of compound heterozygous p.W70X (c.209G>A) and p.R130S (c.390A>C) SLC26A5 variants identified in patients with moderate to profound hearing loss. As in patients, mice carrying one copy of p.R130S Slc26a5 showed OHC dysfunction and progressive degeneration, which results in congenital progressive hearing loss. This is the first functional study reporting pathogenic SLC26A5 variants and pointing to the presence of a therapeutic time window for potential clinical interventions targeting the affected OHCs before they are lost.

S1PR2 Variants Associated with Auditory Function in Humans and Endocochlear Potential Decline in Mouse

A New Mutation of Sgms1 Causes Gradual Hearing Loss Associated with a Reduced Endocochlear Potential

Mouse Screen Reveals Multiple New Genes Underlying Mouse and Human Hearing Loss.

Synaptojanin2 Mutation Causes Progressive High-frequency Hearing Loss in Mice

A Dominant Variant in the PDE1C Gene is Associated with Nonsyndromic Hearing Loss

Spinster Homolog 2 (spns2) Deficiency Causes Early Onset Progressive Hearing Loss.

Pathological mechanisms and candidate therapeutic approaches in the hearing loss of mice carrying human mutations

A Novel PTPRQ c.3697del Variant Causes Autosomal Dominant Progressive Hearing Loss in Both Humans and Mice

Insights into phenotypic differences between humans and mice with p.T721M and other C-terminal variants of the SLC26A4 gene

Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice.

Mutation of the Atp-Gated P2x(2) Receptor Leads to Progressive Hearing Loss and Increased Susceptibility to Noise

Pathological mechanisms and candidate therapeutic approaches in the hearing loss of mice carrying human MIR96 mutations

Mutations in <i>MINAR2</i> encoding membrane integral NOTCH2-associated receptor 2 cause deafness in humans and mice

Two new mouse alleles of Ocm and Slc26a5

A Humanized Mouse Model, Demonstrating Progressive Hearing Loss Caused by MYO6 P.c442y, is Inherited in a Semi-Dominant Pattern

SMPX Deficiency Causes Stereocilia Degeneration and Progressive Hearing Loss in CBA/CaJ Mice

Hearing Loss Andprps1mutations: Wide Spectrum of Phenotypes and Potential Therapy

Toward the Pathogenicity of the SLC26A4 p.C565Y Variant Using a Genetically Driven Mouse Model

Sphingosine 1-phosphate (S1P) signaling is required for maintenance of hair cells mainly via activation of S1P2

Adenosine A2B Receptor: A Pathogenic Factor and a Therapeutic Target for Sensorineural Hearing Loss

The pathogenic roles of the p.R130S prestin variant in DFNB61 hearing loss